Investigating COVID-19 Vaccine Immunity in Children in the Melbourne Infant Study of BCG for Allergy and Infection Reduction
NCT05168709
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Vaccine Reaction
Immunization; Infection
Interventions
BIOLOGICAL:
Tozinameran
Sponsor
Murdoch Childrens Research Institute